Quick Answer
A semaglutide telehealth consultation is a medical visit with a US-licensed physician, conducted online. You complete a detailed health intake, the physician reviews your medical history, medications, and weight history, screens for contraindications, and then decides whether semaglutide is appropriate for you. Depending on your state, the visit is asynchronous (intake review plus messaging) or live video. At Majesta Health the consultation is included in the plan price: $179 your first month, then $299 per month (Essential, compounded semaglutide injection). A legitimate consultation can end without a prescription. The physician decides, not the platform.
What a Semaglutide Telehealth Consultation Actually Is
Telehealth has made GLP-1 care accessible to people far from an obesity-medicine clinic, but the word "consultation" gets stretched by some platforms into something closer to a checkout form. It should not be.
A real semaglutide telehealth consultation has the same clinical components as an in-person visit:
If a website lets you add semaglutide to a cart before any physician has reviewed your health information, that is not a consultation. That is a red flag.
Who Qualifies
The FDA label for Wegovy, the brand-name semaglutide approved for chronic weight management, defines the studied population: adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia.
Telehealth physicians generally start from those same criteria. But two things matter more than the number:
1. The physician makes the final call. BMI is a screening tool, not an approval code. Your full history can rule treatment in or out. 2. A "no" is a valid outcome. If your profile does not support treatment, a legitimate physician will say so and explain why. Platforms that advertise guaranteed approval are advertising the absence of medical judgment.
Asynchronous vs Live Video: Why Your State Matters
Telehealth rules are set state by state. In many states, a physician may evaluate and prescribe based on a thorough asynchronous intake (you answer detailed questions, the physician reviews and messages you). Other states require a synchronous visit, meaning live video, before prescribing.
A legitimate provider handles this automatically: the intake asks for your state, and the platform routes you to the visit type your state requires with a physician licensed there. You should never have to guess. If you want the deeper background, see our guide to how online GLP-1 prescriptions work.
What It Costs
Consultation pricing varies by provider structure:
At Majesta Health, the physician consultation is included: $179 your first month, then $299 per month on the Essential plan (compounded semaglutide injection), or $339 your first month, then $439 per month on the Performance plan (compounded tirzepatide injection). Medication, shipping, and ongoing physician messaging are included, and you can cancel anytime. Our clinical team is listed on our care team page.
Whatever provider you compare, ask one question before paying: "What is my total first-month cost and my total ongoing monthly cost, including every fee?" For the full market picture, see our compounded semaglutide cost breakdown.
What Happens After the Consultation
If the physician prescribes compounded semaglutide, the prescription is written for you individually and sent to a state-licensed compounding pharmacy (section 503A), which prepares your individual prescription and ships it in discreet packaging. Typical delivery is 3 to 5 business days after the prescription is written.
Compounded semaglutide is not FDA-approved as a final product and is not a generic version of, equivalent to, or interchangeable with any brand-name medication. It contains semaglutide as the active pharmaceutical ingredient, meeting United States Pharmacopeia (USP) standards, prepared under an individual prescription. If a brand product is the better clinical or financial fit for you (for example, if your insurance covers Wegovy at a low copay), an honest physician will tell you that too.
Treatment does not end at delivery. Expect scheduled check-ins, dose adjustments through the titration phase, and physician messaging for side-effect questions.
Red Flags in Telehealth Consultations
The Bottom Line
A semaglutide telehealth consultation should feel like real medicine delivered conveniently, not a sales funnel with a medical costume. The physician reviews your history, screens for contraindications, and makes an individual decision. Sometimes that decision is no, and a provider that can tell you no is exactly the kind you want when the answer is yes.
If you want to see whether semaglutide treatment makes sense for you, start with our 2-minute medical assessment. Every treatment decision on Majesta Health is made by a US-licensed physician.
Take the 2-minute medical assessment →
Related guides
This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. Compounded medications are not FDA-approved as final products. Prices reflect published US pricing as of July 2026 and are subject to change. Individual results may vary.
Frequently Asked Questions
What is a semaglutide telehealth consultation?
A semaglutide telehealth consultation is a medical evaluation with a US-licensed physician conducted online, either through a detailed asynchronous intake review or a live video visit, depending on your state's telehealth rules. The physician reviews your medical history, medications, weight history, and contraindications, then decides whether semaglutide treatment is clinically appropriate for you. It is a real medical visit, not a checkout form.
Who qualifies for semaglutide through telehealth?
The FDA label for Wegovy (brand-name semaglutide for weight management) covers adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol. Telehealth physicians generally use these same criteria as a starting point, but the final decision always rests with the licensed physician after reviewing your full history. Meeting a BMI number alone does not guarantee a prescription.
How much does a semaglutide telehealth consultation cost?
It depends on the provider's structure. Some platforms bill the consultation separately from the medication; others bundle it. At Majesta Health the physician consultation is included in the plan price: $179 for your first month, then $299 per month for the Essential plan (compounded semaglutide injection), with medication, shipping, and ongoing physician messaging included. Whatever provider you choose, ask for the all-in monthly cost before you pay anything.
Do I need insurance for a semaglutide telehealth consultation?
No. Telehealth semaglutide programs are typically cash-pay and do not require insurance. That is often the point: patients whose insurance denies weight-loss medication coverage use telehealth as the affordable route. HSA and FSA cards are typically accepted with a valid prescription; confirm with your plan administrator.
Can the telehealth doctor decline to prescribe semaglutide?
Yes, and that is exactly what should happen when treatment is not appropriate. A physician may decline because of contraindications (such as a personal or family history of medullary thyroid carcinoma or MEN 2), a history of pancreatitis, pregnancy or plans to become pregnant, medication interactions, or because your BMI and health profile do not support treatment. Any provider that guarantees approval is not running a legitimate medical evaluation.
What happens after the consultation if semaglutide is prescribed?
The physician writes an individual prescription for you specifically, and it is sent to a state-licensed compounding pharmacy (section 503A) or a retail pharmacy if you are prescribed a brand product. For compounded semaglutide, the pharmacy prepares your prescription and ships it; typical delivery is 3 to 5 business days after the prescription is written. Your treatment then continues with physician oversight through titration and follow-ups.
Majesta Health medical content is written against primary sources (FDA labels, peer-reviewed trials, HHS and CDC publications) and passes a documented compliance review before publication. We are rolling out named physician review with US-licensed clinicians from our partner MD Integrations (MDI): each reviewed article will show the reviewing physician's name, NPI, and review date. MDI is LegitScript certified and SOC 2 Type II accredited.
- US-licensed physicians affiliated with our clinical partner MD Integrations (LegitScript certified, HIPAA, SOC 2 Type II, ISO certified)
- Board-certified in primary care and obesity medicine
- Active state medical licensure required for every prescribing clinician
- Active DEA registration where applicable (note: GLP-1 medications are not controlled substances)
- Telehealth practice across the states we currently serve through the MD Integrations Medical Services Organization (coverage varies by state; see our states page)
- Dispensing pharmacy partner: Belmar Pharma Solutions (LegitScript certified, NABP accredited); Majesta prescriptions are dispensed through Belmar's state-licensed 503A compounding pharmacy